Close

Skip to content

Call now for more information: 1-877-203-1580

Home
About Us
FAQ
How It Works
Learn More
Store

Menu

Home
About Us
FAQ
How It Works
Learn More
Store

See if you qualify: 1-877-203-1580

Home
About Us
FAQ
How It Works
Learn More
Store

Menu

Home
About Us
FAQ
How It Works
Learn More
Store

Wizard

Home
Wizard

1-877-203-1580

Customer Support

How it works
Use Zida Control Stock
Return Policy
FAQ
Contact Us

How it works
Use Zida Control Stock
Return Policy
FAQ
Contact Us

Call Us at 08-611-5526

Healthcare Professionals

Clinical data
Resources
VA

Clinical data
Resources
VA

Footnotes

A clinical study with 21 Zida participants has demonstrated an 80% treatment success rate in reduction of urinary urgency, as well as reductions in frequency and incontinence when compared to a sham device.
Medical device available under prescription only
In a clinical investigation study, the treatment success rate in the ZIDA device arm was 80%, as compared to the treatment success rate of 39% in the sham control arm.
A clinical study (21 participants using Zida device) has demonstrated an average reduction of 71% urge incontinence from baseline to week 12.
A clinical study (21 participants using Zida device) has demonstrated an average reduction of 62% of urgent voids from baseline to week 12.
Based on clinical study survey responses by 21 Zida participants who rated ease of use (average 7.7/10).

The Zida Control Sock, and associated logos, are registered trademarks of ZIDA LLC Copyright @2023 All rights reserved.

Terms and Conditions

Customer Support

How it works
Use Zida Control Stock
Return Policy
FAQ
Contact Us

How it works
Use Zida Control Stock
Return Policy
FAQ
Contact Us

1-877-203-1580

Healthcare Professionals

Clinical data
Resources
VA

Clinical data
Resources
VA

Footnotes

A clinical study with 21 Zida participants has demonstrated an 80% treatment success rate in reduction of urinary urgency, as well as reductions in frequency and incontinence when compared to a sham device.
Medical device available under prescription only
In a clinical investigation study, the treatment success rate in the ZIDA device arm was 80%, as compared to the treatment success rate of 39% in the sham control arm.
A clinical study (21 participants using Zida device) has demonstrated an average reduction of 71% urge incontinence from baseline to week 12.
A clinical study (21 participants using Zida device) has demonstrated an average reduction of 62% of urgent voids from baseline to week 12.
Based on clinical study survey responses by 21 Zida participants who rated ease of use (average 7.7/10).

The Zida Control Sock, and associated logos, are registered trademarks of ZIDA LLC Copyright @2023 All rights reserved.

Privacy Policy
Terms & Conditions